Kaia Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 34)
Kaia Health logo

Kaia Health

EmergingHealthTech

Digital Therapeutics

Kaia Health delivers AI-guided digital physical therapy for musculoskeletal pain via smartphone, using motion tracking to coach patients through personalized exercise programs.

AI VisibilityBeta
Overall Score
D34
Category Rank
#591 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
40
Perplexity
37
Gemini
31

About

Kaia Health's digital therapeutics app uses a smartphone camera and computer vision to track patient movement in real time, providing guided exercise therapy for back pain, hip pain, and COPD without requiring wearable sensors or in-person physical therapy visits. The AI coach analyzes posture and movement quality, providing real-time feedback and adjusting program difficulty as patients improve — replicating key elements of supervised PT in an app-based, self-directed format.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

34
Overall Score
90
#591
Category Rank
#2
74
AI Consensus
83
stable
Trend
stable
40
ChatGPT
92
37
Perplexity
93
31
Gemini
89
37
Claude
96
30
Grok
95

Key Details

Category
Digital Therapeutics
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Kaia Health
Digital Therapeutics

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.